EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses

Ida Paciello, Giulio Pierleoni, Elisa Pantano, Giada Antonelli, Piero Pileri, Giuseppe Maccari, Dario Cardamone, Giulia Realini, Federica Perrone, Martin Mayora Neto, Simone Pozzessere, Massimiliano Fabbiani und 11 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Ida Paciello und 22 weiteren Autor:innen. Beteiligte Einrichtung: Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Neutralizing, COVID-19, Antibodies, Viral. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antibodies, NeutralizingCOVID-19Antibodies, ViralB-LymphocytesHumansCOVID-19 VaccinesAntibodies, MonoclonalSpike Glycoprotein, CoronavirusAntigens, ViralBreakthrough Infections

Stichwörter der Autor:innen

B cell germlinesCOVID-19CP: ImmunologyFc functionsSARS-CoV-2V(D)J genesantigenic sinbreakthrough infectionmemory B cellsneutralizing antibodies

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesAntibodies, MonoclonalSpike Glycoprotein, CoronavirusAntigens, Viral

Autor:innen und Institutionen

  • Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, Italy.
  • Data Science for Health (DaScH) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, Kent, UK.
  • Department of Cellular Therapies, Hematology, and Laboratory Medicine, University Hospital of Siena, Siena, Italy.
  • Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital, Siena, Italy; Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Förderung

  • Wellcome Trust
  • NIAID NIH HHS

Zitieren

APA

Paciello, I., Pierleoni, G., Pantano, E., Antonelli, G., Pileri, P., Maccari, G., Cardamone, D., Realini, G., Perrone, F., Neto, M. M., Pozzessere, S., Fabbiani, M., Panza, F., Rancan, I., Tumbarello, M., Montagnani, F., Medini, D., Maes, P., Temperton, N., …, & Andreano, E. (2024). Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114645

Vancouver

Paciello I, Pierleoni G, Pantano E, Antonelli G, Pileri P, Maccari G, et al. Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114645

BibTeX
@article{Paciello2024,
  author = {Paciello, Ida and Pierleoni, Giulio and Pantano, Elisa and Antonelli, Giada and Pileri, Piero and Maccari, Giuseppe and Cardamone, Dario and Realini, Giulia and Perrone, Federica and Neto, Martin Mayora and Pozzessere, Simone and Fabbiani, Massimiliano and Panza, Francesca and Rancan, Ilaria and Tumbarello, Mario and Montagnani, Francesca and Medini, Duccio and Maes, Piet and Temperton, Nigel and Simon-Loriere, Etienne and Schwartz, Olivier and Rappuoli, Rino and Andreano, Emanuele},
  title = {Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114645}
}
Kostenlos starten →